BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $915,607 (100.0% shares, 0.0% debt)

Holdings (56)

MERUS N V 7.4%
Value ($000) $67,967 Shares 4,639,413 Est. Cost $19.23 Unrealized
CYTK CYTOKINETICS INC 6.4%
Value ($000) $58,240 Shares 5,176,878 Est. Cost $10.21 Unrealized -5.6%
ARRAY BIOPHARMA INC 6.0%
Value ($000) $55,282 Shares 1,193,224 Est. Cost $10.14 Unrealized
ACIU AC IMMUNE SA 6.0%
Value ($000) $54,498 Shares 9,819,434 Est. Cost $6.88 Unrealized -25.9%
MIRATI THERAPEUTICS INC 5.9%
Value ($000) $54,307 Shares 527,253 Est. Cost $59.03 Unrealized
KURA KURA ONCOLOGY INC 4.7%
Value ($000) $43,399 Shares 2,204,119 Est. Cost $12.32 Unrealized +34.7%
BLUEPRINT MEDICINES CORP 4.5%
Value ($000) $41,276 Shares 437,565 Est. Cost $25.16 Unrealized
INFIQ INFINITY PHARMACEUTICALS INC 3.4%
Value ($000) $31,369 Shares 17,426,968 Est. Cost $2.67 Unrealized -39.7%
RCUS ARCUS BIOSCIENCES INC 3.1%
Value ($000) $28,105 Shares 3,535,223 Est. Cost $12.62 Unrealized -20.7%
MOLECULAR TEMPLATES INC 3.0%
Value ($000) $27,192 Shares 3,256,515 Est. Cost $5.50 Unrealized
XOMA XOMA CORP DEL 2.9%
Value ($000) $26,703 Shares 1,796,942 Est. Cost $6.83 Unrealized +119.7%
CALITHERA BIOSCIENCES INC 2.9%
Value ($000) $26,327 Shares 6,750,482 Est. Cost $4.38 Unrealized
REPL REPLIMUNE GROUP INC 2.8%
Value ($000) $25,283 Shares 1,724,609 Est. Cost $15.24 Unrealized -5.1%
CTMX CYTOMX THERAPEUTICS INC 2.3%
Value ($000) $21,022 Shares 1,873,617 Est. Cost $13.23 Unrealized -20.8%
CONCERT PHARMACEUTICALS INC 2.1%
Value ($000) $19,538 Shares 1,628,187 Est. Cost $13.55 Unrealized
DICERNA PHARMACEUTICALS INC 2.1%
Value ($000) $19,277 Shares 1,223,925 Est. Cost $14.97 Unrealized
PIERIS PHARMACEUTICALS INC 2.0%
Value ($000) $18,585 Shares 3,954,264 Est. Cost $4.05 Unrealized
FIVE PRIME THERAPEUTICS INC 2.0%
Value ($000) $18,110 Shares 3,003,342 Est. Cost $14.45 Unrealized
XENE XENON PHARMACEUTICALS INC 1.9%
Value ($000) $17,172 Shares 1,741,600 Est. Cost $9.34 Unrealized +2.4%
SNDX SYNDAX PHARMACEUTICALS INC 1.8%
Value ($000) $16,430 Shares 1,764,784 Est. Cost $8.22 Unrealized -11.3%
IDYA IDEAYA BIOSCIENCES INC 1.6%
Value ($000) $14,994 Shares 1,505,429 Est. Cost $10.88 Unrealized 0.0%
GALMED PHARMACEUTICALS LTD 1.5%
Value ($000) $13,469 Shares 1,832,484 Est. Cost $11.58 Unrealized
CHEMOCENTRYX INC 1.4%
Value ($000) $13,155 Shares 1,414,515 Est. Cost $8.94 Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 1.4%
Value ($000) $12,883 Shares 1,063,802 Est. Cost $9.71 Unrealized +13.9%
AKERO THERAPEUTICS INC 1.4%
Value ($000) $12,416 Shares 648,348 Est. Cost $19.15 Unrealized
ANAB ANAPTYSBIO INC 1.3%
Value ($000) $11,581 Shares 205,265 Est. Cost $23.32 Unrealized +208.8%
SPRO SPERO THERAPEUTICS INC 1.2%
Value ($000) $10,816 Shares 939,704 Est. Cost $12.06 Unrealized -0.1%
CRVS CORVUS PHARMACEUTICALS INC 1.1%
Value ($000) $10,378 Shares 2,774,750 Est. Cost $8.11 Unrealized -51.7%
MERSANA THERAPEUTICS INC 1.1%
Value ($000) $10,116 Shares 2,497,900 Est. Cost $5.26 Unrealized
VERASTEM INC 1.0%
Value ($000) $9,557 Shares 6,328,994 Est. Cost $2.44 Unrealized
BIOLINERX LTD 1.0%
Value ($000) $9,488 Shares 25,995,575 Est. Cost $1.01 Unrealized
FORWARD PHARMA A/S 1.0%
Value ($000) $8,734 Shares 8,480,079 Est. Cost $5.84 Unrealized
X4 PHARMACEUTICALS INC 1.0%
Value ($000) $8,708 Shares 580,500 Est. Cost $15.00 Unrealized
PREVAIL THERAPEUTICS INC 0.9%
Value ($000) $8,666 Shares 656,483 Est. Cost $13.20 Unrealized
ARQULE INC 0.9%
Value ($000) $8,516 Shares 773,459 Est. Cost $1.85 Unrealized
GNCAQ GENOCEA BIOSCIENCES INC 0.9%
Value ($000) $8,233 Shares 2,100,305 Est. Cost $5.22 Unrealized 0.0%
EIGER BIOPHARMACEUTICALS INC 0.8%
Value ($000) $7,155 Shares 675,000 Est. Cost $10.16 Unrealized
OVID OVID THERAPEUTICS INC 0.7%
Value ($000) $6,629 Shares 3,583,236 Est. Cost $2.44 Unrealized -26.9%
CTI BIOPHARMA CORP 0.7%
Value ($000) $5,955 Shares 6,929,690 Est. Cost $3.77 Unrealized
MEI PHARMA INC 0.6%
Value ($000) $5,553 Shares 2,221,272 Est. Cost $3.94 Unrealized
GAMIDA CELL LTD 0.6%
Value ($000) $5,080 Shares 1,000,000 Est. Cost $5.08 Unrealized
SUNESIS PHARMACEUTICALS INC 0.5%
Value ($000) $4,921 Shares 6,770,425 Est. Cost $1.41 Unrealized
ALPINE IMMUNE SCIENCES INC 0.5%
Value ($000) $4,849 Shares 1,151,717 Est. Cost $9.40 Unrealized
SPRING BK PHARMACEUTICALS INC 0.5%
Value ($000) $4,803 Shares 1,301,701 Est. Cost $10.79 Unrealized
ERYTECH PHARMA 0.5%
Value ($000) $4,481 Shares 625,000 Est. Cost $22.02 Unrealized
CIDARA THERAPEUTICS INC 0.5%
Value ($000) $4,457 Shares 2,652,895 Est. Cost $3.33 Unrealized
ESSA PHARMA INC 0.3%
Value ($000) $3,085 Shares 1,329,700 Est. Cost $2.94 Unrealized
SURFACE ONCOLOGY INC 0.3%
Value ($000) $2,880 Shares 1,021,234 Est. Cost $7.57 Unrealized
REALM THERAPEUTICS PLC 0.3%
Value ($000) $2,566 Shares 909,759 Est. Cost $3.30 Unrealized
REGULUS THERAPEUTICS INC 0.3%
Value ($000) $2,545 Shares 2,035,695 Est. Cost $1.09 Unrealized
KARYOPHARM THERAPEUTICS INC 0.2%
Value ($000) $2,128 Shares 355,266 Est. Cost $5.99 Unrealized
ALBIREO PHARMA INC 0.2%
Value ($000) $2,112 Shares 65,500 Est. Cost $32.57 Unrealized
VICAL INC 0.2%
Value ($000) $1,555 Shares 1,829,059 Est. Cost $1.56 Unrealized
MREO MEREO BIOPHARMA GROUP PLC 0.1%
Value ($000) $1,256 Shares 523,382 Est. Cost $2.40 Unrealized
CONTRAFECT CORP 0.1%
Value ($000) $968 Shares 1,898,990 Est. Cost $1.14 Unrealized
NOVUS THERAPEUTICS INC 0.1%
Value ($000) $837 Shares 828,876 Est. Cost $1.01 Unrealized